Interferon-bèta Enhances Sensitivity to Gemcitabine in Pancreatic Cancer
Amber Blaauboer(Erasmus MC), Leo J. Hofland(Erasmus MC)
Cited by 0
Related Papers
The Pathophysiological Consequences of Somatostatin Receptor Internalization and Resistance
|Endocrine Reviews|2003|475
The Medical Treatment of Cushing’s Disease: Effectiveness of Chronic Treatment with the Dopamine Agonist Cabergoline in Patients Unsuccessfully Treated by Surgery
|The Journal of Clinical Endocrinology & Metabolism|2008|326
Telomerase reverse transcriptase promoter mutations in tumors originating from the adrenal gland and extra-adrenal paraganglia
|Endocrine Related Cancer|2014|43
Characterization of the mTOR pathway in human normal adrenal and adrenocortical tumors
|Endocrine Related Cancer|2014|25
Interferon-beta enhances sensitivity to gemcitabine in pancreatic cancer
|BMC Cancer|2020|16